Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

2.27p
   
  • Change Today:
      0.045p
  • 52 Week High: 3.93
  • 52 Week Low: 1.10
  • Currency: UK Pounds
  • Shares Issued: 979.75m
  • Volume: 22,354,163
  • Market Cap: £22.24m
  • RiskGrade: 340

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-22 Interim n/a (1.14) (0.20)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 n/a (2.41) (0.91)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (1.59) (0.40)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (1.49) (0.40)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (2.10) (0.50)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (5.11) (0.70)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Forecasts data is not available for this company.

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

HEMO Market Data

Currency UK Pounds
Share Price 2.27p
Change Today 0.045p
% Change 2.02 %
52 Week High 3.93
52 Week Low 1.10
Volume 22,354,163
Shares Issued 979.75m
Market Cap £22.24m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.75% below the market average19.75% below the market average19.75% below the market average19.75% below the market average19.75% below the market average
20.69% below the sector average20.69% below the sector average20.69% below the sector average20.69% below the sector average20.69% below the sector average
Price Trend
46.62% above the market average46.62% above the market average46.62% above the market average46.62% above the market average46.62% above the market average
58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 01-Feb-2023

Time Volume / Share Price
17:12 500,000 @ 2.27p
17:12 750,769 @ 2.27p
15:05 700,000 @ 2.30p
16:36 500,000 @ 2.27p
16:35 400,000 @ 2.27p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page